Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease - PubMed (original) (raw)
Subthalamic nucleus lesions reduce low frequency oscillatory firing of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease
K Y Tseng et al. Brain Res. 2001.
Abstract
Single unit recordings performed in animal models of Parkinson's disease revealed that output nuclei neurons display modifications in firing pattern and firing rate, which are supposed to give rise to the clinical manifestations of the illness. We examined the activity pattern of single units from the substantia nigra pars reticulata, the main output nuclei of the rodent basal ganglia, in urethane-anesthetized control and 6-hydroxydopamine-lesioned rats (a widespread model of Parkinson's disease). We further studied the effect of a subthalamic nucleus lesion in both experimental groups. Subthalamic nucleus lesion produces behavioral improvement in animal models of Parkinson's disease, and was expected to reverse the changes induced by 6-hydroxydopamine lesions. A meticulous statistical investigation, which included a non-biased classification of the recorded units by means of cluster analysis, allowed us to identify a low frequency oscillation of firing rate ( approximately 0.9 Hz) occurring in approximately 35% of the units recorded from 6-hydroxydopamine-lesioned rats, as the main feature differentiating 6-hydroxydopamine-lesioned and control rats. Subthalamic nucleus lesions significantly reduced the proportion of oscillatory units in 6-hydroxydopamine-lesioned rats. However, the population of nigral units recorded from rats bearing both lesions still differed significantly from control units. These results suggest that oscillatory activity in the basal ganglia output nuclei may be related to some clinical features of parkinsonism, and suggest a putative mechanism through which therapeutic interventions aimed at modifying subthalamic nucleus function produce clinical benefit in Parkinson's disease.
Similar articles
- Spreading of slow cortical rhythms to the basal ganglia output nuclei in rats with nigrostriatal lesions.
Belluscio MA, Kasanetz F, Riquelme LA, Murer MG. Belluscio MA, et al. Eur J Neurosci. 2003 Mar;17(5):1046-52. doi: 10.1046/j.1460-9568.2003.02543.x. Eur J Neurosci. 2003. PMID: 12653980 - Substantia nigra pars reticulata units in 6-hydroxydopamine-lesioned rats: responses to striatal D2 dopamine receptor stimulation and subthalamic lesions.
Tseng KY, Riquelme LA, Belforte JE, Pazo JH, Murer MG. Tseng KY, et al. Eur J Neurosci. 2000 Jan;12(1):247-56. doi: 10.1046/j.1460-9568.2000.00910.x. Eur J Neurosci. 2000. PMID: 10651879 - Dopamine regulates the impact of the cerebral cortex on the subthalamic nucleus-globus pallidus network.
Magill PJ, Bolam JP, Bevan MD. Magill PJ, et al. Neuroscience. 2001;106(2):313-30. doi: 10.1016/s0306-4522(01)00281-0. Neuroscience. 2001. PMID: 11566503 - Substantia nigra control of basal ganglia nuclei.
Guatteo E, Cucchiaroni ML, Mercuri NB. Guatteo E, et al. J Neural Transm Suppl. 2009;(73):91-101. doi: 10.1007/978-3-211-92660-4_7. J Neural Transm Suppl. 2009. PMID: 20411770 Review. - Functional changes of the basal ganglia circuitry in Parkinson's disease.
Blandini F, Nappi G, Tassorelli C, Martignoni E. Blandini F, et al. Prog Neurobiol. 2000 Sep;62(1):63-88. doi: 10.1016/s0301-0082(99)00067-2. Prog Neurobiol. 2000. PMID: 10821982 Review.
Cited by
- Altered neuronal activity relationships between the pedunculopontine nucleus and motor cortex in a rodent model of Parkinson's disease.
Aravamuthan BR, Bergstrom DA, French RA, Taylor JJ, Parr-Brownlie LC, Walters JR. Aravamuthan BR, et al. Exp Neurol. 2008 Oct;213(2):268-80. doi: 10.1016/j.expneurol.2008.05.023. Epub 2008 Jun 9. Exp Neurol. 2008. PMID: 18601924 Free PMC article. - Beta frequency synchronization in basal ganglia output during rest and walk in a hemiparkinsonian rat.
Avila I, Parr-Brownlie LC, Brazhnik E, Castañeda E, Bergstrom DA, Walters JR. Avila I, et al. Exp Neurol. 2010 Feb;221(2):307-19. doi: 10.1016/j.expneurol.2009.11.016. Epub 2009 Dec 4. Exp Neurol. 2010. PMID: 19948166 Free PMC article. - Cannabinoids differentially modulate cortical information transmission through the sensorimotor or medial prefrontal basal ganglia circuits.
Antonazzo M, Gutierrez-Ceballos A, Bustinza I, Ugedo L, Morera-Herreras T. Antonazzo M, et al. Br J Pharmacol. 2019 Apr;176(8):1156-1169. doi: 10.1111/bph.14613. Epub 2019 Mar 18. Br J Pharmacol. 2019. PMID: 30735570 Free PMC article. - The pharmacological blockade of medial forebrain bundle induces an acute pathological synchronization of the cortico-subthalamic nucleus-globus pallidus pathway.
Galati S, Stanzione P, D'Angelo V, Fedele E, Marzetti F, Sancesario G, Procopio T, Stefani A. Galati S, et al. J Physiol. 2009 Sep 15;587(Pt 18):4405-23. doi: 10.1113/jphysiol.2009.172759. Epub 2009 Jul 21. J Physiol. 2009. PMID: 19622605 Free PMC article. - Abnormal Bursting as a Pathophysiological Mechanism in Parkinson's Disease.
Lobb C. Lobb C. Basal Ganglia. 2014 Apr 1;3(4):187-195. doi: 10.1016/j.baga.2013.11.002. Basal Ganglia. 2014. PMID: 24729952 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous